INS and lung cancer: Tseng et al. observed that insulin users who also had chronic obstructive pulmonary disease had the highest risk of lung cancer when compared to patients without insulin use and without chronic obstructive pulmonary disease, (adjusted hazard ratio: 1.891, 95% confidence interval: 1.767–2.024) [38].